mdpi logo

 Special Issue

"Biomarkers for Diagnosis, Complications and Therapy Effects in Civilization Diseases Management"

Journal of Clinical Medicine (IMAPCT FACTOR 3.303)

Deadline for manuscript submissions: 21 May 2021

Dear Colleagues,

 

The prevalence of civilization diseases i.e., cancer, diabetes, obesity, and autoimmune diseases have shown an exponential worldwide rise in recent years. The development of molecular, biotechnological, and genetic tools has provided valuable diagnostic tools to the clinical practice based on new molecules, proteins, as well as genes, which are not only involved in the pathogenesis of civilization diseases but are also used as markers to assess the effectiveness of therapy or to predict development of complications. Today, a diversity of the available diagnostic tools have helped physicians to change the way of approaching diseases of civilization toward the concept of personalized medicine. In this Special Issue, we invite investigators to contribute either original research or review articles focusing on the role of new proteins, molecular, and genetic markers that can be used for the diagnosis and monitoring of the progression of the several complications linked to civilization diseases as well as biomarkers useful in monitoring the effects of the implemented treatment. At the same time, we invite researchers to submit either original research or review articles having civilization diseases as the main topic concentrating on the latest diagnostic tools and possible use of them as biomarkers for health and disease.

You may send your manuscript now or up until the deadline.

Detailed information: https://www.mdpi.com/journal/jcm/special_issues/civilization_diseases_management

Guest Editors

Prof. Katarzyna Komosinska-Vassev Prof. Pawel Olczyk
Prof. Katarzyna Komosinska-Vassev Prof. Pawel Olczyk

 

Szanowni Państwo,

Pragniemy poinformować, że Pani prof. dr hab. Katarzyna Komosińska-Vassev oraz Pan prof. dr hab. Paweł Olczyk zostali Gościnnymi Edytorami wydania specjalnego "Biomarkers for Diagnosis, Complications and Therapy Effects in Civilization Diseases Management" w czasopiśmie Journal of Clinical Medicine (IF = 3.303). Termin nadsyłania prac mija 21 maja 2021 roku.

Link do strony wydawnictwa https://www.mdpi.com/journal/jcm/special_issues/civilization_diseases_management

 

[Przesłano przez: Ewa Jasiejko]